Advanced Biomed (ADVB) Annual Income Statement

Annual · GAAP · USD millions
Access ADVB quarterly income statements →
From Advanced Biomed through , changes in Jun 30 2024's revenue and cost structure provide insight into profitability trends.
Annual Report, GAAP in USD millions
ITEM
(Jun 30 2024)
2025
Revenues
Total Revenue0.00
Costs & Expenses
Gross Profit0.00
Selling, Administration, Marketing1.66
Depreciation & Amortization0.67
Research & Development0.88
Total operating costs including COS2.54
Operating income / -loss0.00
Net Interest (-)Expense / Income0.00
Loss / -Gain on Investment0.05
Total costs & expenses0.00
Income & Taxes
Income / -loss before income taxes-2.78
Income after income taxes0.00
Income / -loss from continuing operations-2.78
Net income / -loss-2.78
Income / -loss to shareholder-2.78
EBIT-2.78
EBITD-1.59
EBITDA-1.46
Earnings Per Share
Basic EPS (excl. extra items)-0.16
Basic Net EPS-0.16
Basic shares outstanding (Mill. of Units)20.53
Diluted Net EPS-0.16
Diluted average shares (Mill. of Units)20.53
4 historic quarters locked

Sign in to unlock the full Advanced Biomed income statement history.

About Advanced Biomed Inc Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.